Last10K.com

Jaguar Health, Inc. (JAGX) SEC Filing 8-K Material Event for the period ending Wednesday, February 27, 2019

SEC Filings

JAGX Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

JAGX Annual Reports

JAGX Quarterly Reports

JAGX Corporate News

JAGX Registration of Securities

Jaguar Health, Inc.

HISTORY TOOLS
CIK: 1585608 Ticker: JAGX

View differences made from one to another to evaluate Jaguar Health, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Jaguar Health, Inc..

Continue

Assess how Jaguar Health, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Jaguar Health, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Jaguar Health, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: JAGX
CIK: 1585608
Form Type: 8-K Corporate News
Accession Number: 0001104659-19-012754
Submitted to the SEC: Tue Mar 05 2019 9:00:56 AM EST
Accepted by the SEC: Tue Mar 05 2019
Period: Wednesday, February 27, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Unregistered Sales
  3. Vote of Security Holders

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/jagx/0001104659-19-012754.htm